Cart
0

Metagenomics Market by Technology (Sequencing, and Bioinformatics) and by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_183724
Pages: NA
Oct 2018 | 821 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Metagenomics (also referred to as community and environmental genomics), is the genomic study of microorganisms where the DNA of the microorganism is extracted directly and cloned from an assembly of the microorganism.

Factors such as the development of inexpensive next generation sequencing (NGS) technologies, high throughput screening (HTS) methods, use of advanced bioinformatics tools such as genome assemblers & gene predictors, and recovery of many novel drugs, antibiotics, & enzymes or isoenzymes drive the market growth. However, limited accessibility of enzyme activity assay and the narrow choice of host in transformation acts as a constraint in the growth of the metagenomics market. In addition, R&D to identify new enzymes and antibiotics, and improved bioinformatics offer attractive opportunities for the key market players.

The global metagenomics market is segmented on the basis of technology, application, and region. Based on the technology, the market is divided into sequencing and bioinformatics. According to application, it is classified into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, ecology, and agriculture. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies of the metagenomics market include SciGenom Labs Pvt. Ltd, ENTEROME Bioscience, Aperiomics, Inc., The MITRE Corporation, Quest Diagnostics Incorporated., GATC Biotech AG., Freenome Inc., GenapSys, Inc., COSMOSID, and SECOND GENOME THERAPEUTICS.

Key Benefits

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market by type assists in understanding the regional trends.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Metagenomics Market Key Segments:

By Technology

  • Sequencing
  • Bioinformatics

By Applications

  • Infectious Disease Diagnosis
  • Environmental Remediation
  • Gut Microbe Characterization
  • Biotechnology
  • Biofuel
  • Ecology
  • Agriculture

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter 1 INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter 3 MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning/ Market Share Analysis, 2017
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter 4 METAGENOMICS MARKET, BY TECHNOLOGY

4.1. Overview
4.1.1. Market size and forecast
4.2. Sequencing
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. 16s rRNA Sequencing
4.2.2.1.1. Market size and forecast
4.2.2.2. Metagenomic Sequencing
4.2.2.2.1. Market size and forecast
4.2.2.3. High-throughput Sequencing
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Bioinformatics
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

Chapter 5 METAGENOMICS MARKET, BY APPLICATION

5.1. Overview
5.1.1. Market size and forecast
5.2. Infectious Disease Diagnosis
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Environmental Remediation
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Gut Microbe Characterization
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Biotechnology
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Biofuel
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Ecology
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
5.8. Agriculture
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country
5.9. Other Applications
5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by country

Chapter 6 METAGENOMICS MARKET, BY PRODUCT

6.1. Overview
6.1.1. Market size and forecast
6.2. Laboratory Instruments
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Analyzers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Consumables
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Kits & Reagents
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
6.6. Services
6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country

Chapter 7 METAGENOMICS MARKET, BY GEOGRAPHY

7.1. Overview
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America metagenomics market, by country
7.2.2.1. U.S. metagenomics market
7.2.2.1.1. U.S. market, by technology
7.2.2.1.2. U.S. market, by application
7.2.2.1.3. U.S. market, by product
7.2.2.2. Canada metagenomics market
7.2.2.2.1. Canada market, by technology
7.2.2.2.2. Canada market, by application
7.2.2.2.3. Canada market, by product
7.2.2.3. Mexico metagenomics market
7.2.2.3.1. Mexico market, by technology
7.2.2.3.2. Mexico market, by application
7.2.2.3.3. Mexico market, by product
7.2.3. North America metagenomics market, by technology
7.2.4. North America metagenomics market, by application
7.2.5. North America metagenomics market, by product
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe metagenomics market, by country
7.3.2.1. Germany metagenomics market
7.3.2.1.1. Germany market, by technology
7.3.2.1.2. Germany market, by application
7.3.2.1.3. Germany market, by product
7.3.2.2. France metagenomics market
7.3.2.2.1. France market, by technology
7.3.2.2.2. France market, by application
7.3.2.2.3. France market, by product
7.3.2.3. UK metagenomics market
7.3.2.3.1. UK market, by technology
7.3.2.3.2. UK market, by application
7.3.2.3.3. UK market, by product
7.3.2.4. Italy metagenomics market
7.3.2.4.1. Italy market, by technology
7.3.2.4.2. Italy market, by application
7.3.2.4.3. Italy market, by product
7.3.2.5. Spain metagenomics market
7.3.2.5.1. Spain market, by technology
7.3.2.5.2. Spain market, by application
7.3.2.5.3. Spain market, by product
7.3.2.6. Rest of Europe metagenomics market
7.3.2.6.1. Rest of Europe market, by technology
7.3.2.6.2. Rest of Europe market, by application
7.3.2.6.3. Rest of Europe market, by product
7.3.3. Europe metagenomics market, by technology
7.3.4. Europe metagenomics market, by application
7.3.5. Europe metagenomics market, by product
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific metagenomics market, by country
7.4.2.1. Japan metagenomics market
7.4.2.1.1. Japan market, by technology
7.4.2.1.2. Japan market, by application
7.4.2.1.3. Japan market, by product
7.4.2.2. China metagenomics market
7.4.2.2.1. China market, by technology
7.4.2.2.2. China market, by application
7.4.2.2.3. China market, by product
7.4.2.3. India metagenomics market
7.4.2.3.1. India market, by technology
7.4.2.3.2. India market, by application
7.4.2.3.3. India market, by product
7.4.2.4. Australia metagenomics market
7.4.2.4.1. Australia market, by technology
7.4.2.4.2. Australia market, by application
7.4.2.4.3. Australia market, by product
7.4.2.5. Rest of Asia-Pacific metagenomics market
7.4.2.5.1. Rest of Asia-Pacific market, by technology
7.4.2.5.2. Rest of Asia-Pacific market, by application
7.4.2.5.3. Rest of Asia-Pacific market, by product
7.4.3. Asia-Pacific metagenomics market, by technology
7.4.4. Asia-Pacific metagenomics market, by application
7.4.5. Asia-Pacific metagenomics market, by product
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA metagenomics market, by country
7.5.2.1. Brazil metagenomics market
7.5.2.1.1. Brazil market, by technology
7.5.2.1.2. Brazil market, by application
7.5.2.1.3. Brazil market, by product
7.5.2.2. Saudi Arabia metagenomics market
7.5.2.2.1. Saudi Arabia market, by technology
7.5.2.2.2. Saudi Arabia market, by application
7.5.2.2.3. Saudi Arabia market, by product
7.5.2.3. South Africa metagenomics market
7.5.2.3.1. South Africa market, by technology
7.5.2.3.2. South Africa market, by application
7.5.2.3.3. South Africa market, by product
7.5.2.4. Rest of LAMEA metagenomics market
7.5.2.4.1. Rest of LAMEA market, by technology
7.5.2.4.2. Rest of LAMEA market, by application
7.5.2.4.3. Rest of LAMEA market, by product
7.5.3. LAMEA metagenomics market, by technology
7.5.4. LAMEA metagenomics market, by application
7.5.5. LAMEA metagenomics market, by product

Chapter 8 COMPANY PROFILES

8.1. Enterome SA
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. Illumina Inc.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. F. Hoffmann-La Roche Ltd
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. Eurofins Genomics
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. SciGenom Labs
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. Quest Diagnostics Incorporated
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. Freenome Inc.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. GenapSys, Inc.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. Thermo Fisher Scientific Inc.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. Second Genome Therapeutics
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Metagenomics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo